Commonwealth Bank of Australia’s PDL BioPharma, Inc. PDLI Stock Holding History

Commonwealth Bank of Australia’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-454,342	Closed	-$3.77M	–	1229
2014 Q1	$3.77M	Buy	454,342 +69,560	+18%	+$596K	0.02%	509
2013 Q4	$3.25M	Buy	384,782 +16,400	+4%	+$138K	0.02%	519
2013 Q3	$2.94M	Hold	368,382	–	–	0.02%	510
2013 Q2	$2.84M	Buy	+368,382	New	+$2.87M	0.02%	502

Other funds holding PDLI

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Bank of Australia's PDLI Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of PDL BioPharma, Inc. (PDLI) in Q2 2014, closing a stake of 454,342 shares — an estimated $3.77M sold.

Commonwealth Bank of Australia first reported a position in PDLI in Q2 2013 and held it in 4 quarters. The position peaked at $3.77M in Q1 2014. 222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

Commonwealth Bank of Australia reported no remaining PDL BioPharma, Inc. position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 454,342 PDL BioPharma, Inc. shares in Q2 2014, an estimated $3.77M.
Commonwealth Bank of Australia first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 4 quarters.
Commonwealth Bank of Australia's PDL BioPharma, Inc. position peaked at $3.77M in Q1 2014.
222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.